Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannous fluoride dentifrices for gingivitis
NCT07158112Phase 4Active, not recruiting
- Sponsor
- Procter & Gamble
- Start
- Aug 2025
- Primary completion
- Dec 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised trial of stannous fluoride in gingivitis (3 arms), sponsored by Procter & Gamble. Primary endpoint: Number of Bleeding Sites at 3 months. Started Aug 2025; status: active, not recruiting.
02
Drugs
stannous fluoride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT07158112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07158112.